EARTH-STEMI - Complete vs. culprit-only revascularisation in older STEMI patients

Reported from ESC Congress 2024

Aaysha Cader interviews Gianluca Campo about the EARTH-STEMI trial he presented at ESC Congress 2024 in London.

This meta-analysis aimed to evaluate a large cohort of STEMI patients, predominantly comorbid, with a mean age of 79 and extended long-term follow-up. The key findings revealed that complete revascularisation reduced the risk of cardiac death or MI by 24 % over a 4-year follow-up period.